High incidence of fistula formation during bevacizumab treatment in rectal cancer patients.
Wolf
Ido
I
Urban
Damien
D
Pfeffer
Raphael
R
Catane
Raphael
R
Aderka
Dan
D
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012003:Rectal Fistula / Q000139:chemically induced* / Q000000981:diagnostic imaging; D012004:Rectal Neoplasms / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab